These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 13443201)
1. Treatment of viral syndromes with a lipoprotein-nucleic acid compound (reticulose); a report of five cases. ANDERSON RH; THOMPSON RM Va Med Mon (1918); 1957 Jul; 84(7):347-53. PubMed ID: 13443201 [No Abstract] [Full Text] [Related]
2. The effect of reticulose on viral infections of experimental animals. BEHBEHANI AM; HABERMAN S; RACE GJ South Med J; 1962 Feb; 55():185-8. PubMed ID: 13866577 [No Abstract] [Full Text] [Related]
4. The efficacy of a peptide-nucleic acid solution (Reticulose) for the treatment of hepatitis A and hepatitis B--a preliminary controlled human clinical trial. Cohen M J R Soc Health; 1992 Dec; 112(6):266-70. PubMed ID: 1469671 [TBL] [Abstract][Full Text] [Related]
5. Failure to demonstrate antiviral activity of reticulose. KEMPE CH; FULGINITI VA; ST VINCENT L Am J Dis Child; 1962 May; 103():655-7. PubMed ID: 14455085 [No Abstract] [Full Text] [Related]
6. [Reticulose in the protection of the rabbit inoculated with antivariola vaccine virus]. RUIZ SANCHEZ F; RUIZ SANCHEZ A; LAMAS E; ALDRETE A Medicina (Mex); 1962 Sep; 42():365-7. PubMed ID: 13983258 [No Abstract] [Full Text] [Related]
7. Peptide nucleic acids stimulate gamma interferon and inhibit the replication of the human immunodeficiency virus. Hirschman SZ; Chen CW J Investig Med; 1996 Aug; 44(6):347-51. PubMed ID: 8795297 [TBL] [Abstract][Full Text] [Related]
8. Failure of reticulose to reduce radiation lethality in mice and rats. SMITH WW; RUTH HJ; CANTER HY Proc Soc Exp Biol Med; 1952 Oct; 81(1):116-8. PubMed ID: 13047331 [No Abstract] [Full Text] [Related]
10. Application of PNA and LNA oligomers to chemotherapy. Elayadi AN; Corey DR Curr Opin Investig Drugs; 2001 Apr; 2(4):558-61. PubMed ID: 11566018 [TBL] [Abstract][Full Text] [Related]
11. Nucleic acids and their role in future chemotherapy of tumours and virus diseases. TODD A Br Med J; 1959 Sep; 2(5151):517-22. PubMed ID: 13838611 [No Abstract] [Full Text] [Related]
12. In vitro antiviral activity of a peptide-nucleic acid solution against the human immunodeficiency virus and influenza A virus. Friedland B J R Soc Health; 1991 Oct; 111(5):170-1. PubMed ID: 1724467 [TBL] [Abstract][Full Text] [Related]
13. Activation of Innate Immunity by Therapeutic Nucleic Acids. Bishani A; Chernolovskaya EL Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948156 [TBL] [Abstract][Full Text] [Related]
14. Backbone modification of nucleic acids: synthesis, structure and therapeutic applications. Micklefield J Curr Med Chem; 2001 Aug; 8(10):1157-79. PubMed ID: 11472234 [TBL] [Abstract][Full Text] [Related]
15. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids. Nimesh S; Gupta N; Chandra R J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455 [TBL] [Abstract][Full Text] [Related]
16. Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art. Vahdat Lasemi F; Mahjoubin Tehran M; Aghaee-Bakhtiari SH; Jalili A; Jaafari MR; Sahebkar A Drug Discov Today; 2019 May; 24(5):1116-1131. PubMed ID: 30980904 [TBL] [Abstract][Full Text] [Related]
17. Use of a lipoprotein-nucleic acid compound in treatment of infectious mononucleosis. MEDOFF LR Clin Med (Northfield); 1962 Jan; 69():101-4. PubMed ID: 15445825 [No Abstract] [Full Text] [Related]
18. [Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell]. Cavagnari BM Arch Argent Pediatr; 2011 Jun; 109(3):237-44. PubMed ID: 21660389 [TBL] [Abstract][Full Text] [Related]